FindTrial
Sign In

Dentin hypersensitivity:A randomised clinical trial on the efficacy of 5% Fluorocalcium phosphosilicate containing novel bioactive glass dentifrice.

A Randomised,Triple blind,Two treatment, Parallel design study of the efficacy of Fluorocalcium phosphosilicate containing novel toothpaste on dentinal hypersensitivity.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/05/014136
Enrollment
75
Registered
2018-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Dentinal Hypersensitivity

Interventions

Intervention1: 5% Fluorocalcium phosphosilicate: Group-A was given 5% Fluorocalcium phosphosilicate based on Biomin-F formulation for 1 month twice daily Control Intervention1: 8% Arginine and Calcium

Sponsors

SDM College of Dental Sciences and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with a gingival index score of less than or equal to 2. 2. Patients who are medically/systemically fit. 3. Patients of both genders of age 18-70 years. 4. Patients with no dental problem/active periodontitis/anyother condition which can explain tooth sensitivity. 5. Non-lactating females. 6. Non-smokers. 7. Patients who are compliant with the study.

Exclusion criteria

Exclusion criteria: 1. Current desensitizing therapy 2. Medical (including psychiatric) and pharmacotherapeutic histories that may compromise the protocol â?? including the chronic use of anti-inflammatory, analgesic and mind-altering drugs. 3. Allergies and idiosyncratic responses to product ingredients. 4. Periodontal surgery in the preceding 3 months. 5. Orthodontic appliance treatment within previous 3 months. 6. Teeth or supporting structures "with any other painful pathology or defects. 7. Teeth restored in the preceding 3 months and those with restorations extending into the test area. 8. Abutment teeth for fixed or removable prostheses.

Design outcomes

Primary

MeasureTime frame
The primary outcome was to assess the efficacy of 5% Fluorocalcium phosphosilicate containing novel bioactive glass toothpaste in managing dentinal hypersensitivityTimepoint: 15 days and 1 month—

Secondary

MeasureTime frame
The secondary outcome was to assess the antibacterial effects of 5% Fluorocalcium phosphosilicate by measuring the PI and GI at pre-baseline, after 15 days and after 1 monthTimepoint: At pre-baseline, 15 days and 1 month—

Countries

India

Contacts

Public ContactDr Vivek R Patel

SDM College of Dental Sciences and Hospital

leenagcp@rediffmail.com9480218312

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026